Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! Lots of news ...

Akero reported Monday strong results showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused ...

An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

The WHO and the CDC coordinated well when faced with viral outbreaks. This is no time to demolish a well-oiled machine.

We ran out of money. Plain and simple,” Equality AI's CEO Maia Hightower said, days after she decided to shut down her ...

During the LA fires, health care workers who didn’t know if their own homes were still standing set out to find patients who ...

The article had to be pulled even though HHS Office of Research Integrity officials gave a public talk on the topic last fall ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...